Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 55
Filter
1.
Sci Rep ; 13(1): 6101, 2023 Apr 13.
Article in English | MEDLINE | ID: mdl-37055539

ABSTRACT

Solar flares are one of the severest solar activities that have important effects on near-Earth space. Previous studies have shown that flight arrival delays increase as a result of solar flares, but the intrinsic mechanism behind this relationship is still unknown. In this study, we conducted a comprehensive analysis of flight departure delays during 57 solar X-ray events by using a huge amount of flight data (~ 5 × 106 records) gathered over a 5-year period. It is found that the average flight departure delay time during solar X-ray events increased by 20.68% (7.67 min) compared to quiet periods. Our analysis also revealed apparent time and latitude dependencies, with flight delays being more serious on the dayside than on the nightside and longer (shorter) delays tending to occur in lower (higher) latitude airports during solar X-ray events. Furthermore, our results suggest that the intensity of solar flares (soft X-ray flux) and the Solar Zenith Angle directly modulate flight departure delay time and delay rate. These results indicate that communication interferences caused by solar flares directly affect flight departure delays. This work expands our conventional understanding of the impacts of solar flares on human society and provides new insights for preventing or coping with flight delays.

2.
Sci Rep ; 13(1): 3246, 2023 Feb 24.
Article in English | MEDLINE | ID: mdl-36828884

ABSTRACT

Although the sun is really far away from us, some solar activities could still influence the performance and reliability of space-borne and ground-based technological systems on Earth. Those time-varying conditions in space caused by the sun are also called solar storm or space weather. It is known that aviation activities can be affected during solar storms, but the exact effects of space weather on aviation are still unclear. Especially how the flight delays, the top topic concerned by most people, will be affected by space weather has never been thoroughly researched. By analyzing huge amount of flight data (~ 4 × 106 records), for the first time, we quantitatively investigate the flight delays during space weather events. It is found that compared to the quiet periods, the average arrival delay time and 30-min delay rate during space weather events are significantly increased by 81.34% and 21.45% respectively. The evident negative correlation between the yearly flight regularity rate and the yearly mean total sunspot number during 22 years also confirms such correlation. Further studies show that the flight delay time and delay rate will monotonically increase with the geomagnetic field fluctuations and ionospheric disturbances. These results indicate that the interferences in communication and navigation during space weather events may be the most probable reason accounting for the increased flight delays. The above analyses expand the traditional field of space weather research and could also provide us with brand new views for improving the flight delay predications.

3.
Article in Chinese | MEDLINE | ID: mdl-35785906

ABSTRACT

Ultraviolet radiation affects human health. On the one hand, moderate amounts of UV radiation can promote human health and have the effect of promoting vitamin D production; but on the other hand, excessive UV radiation can also cause adverse effects on human skin and eyes, such as causing skin photoaging, skin cancer, electrophthalmia and cataracts to occur. Therefore, the measurement of ultraviolet radiation is extremely important. This paper mainly reviews the health effects of ultraviolet radiation and the progress of measurement standards in the workplace, and puts forward suggestions on the revision of the existing standards from five aspects including use new measuring instruments and methods, improve the existing measuring instruments, specify the number of measurements, expand the scope of application of the standards and consider the influence of the sun on the measurement of artificial ultraviolet radiation, so as to provide reference for the revision of new standards.


Subject(s)
Skin Neoplasms , Ultraviolet Rays , Humans , Skin , Skin Neoplasms/etiology , Ultraviolet Rays/adverse effects , Vitamin D/radiation effects , Workplace
4.
Zhonghua Yi Xue Za Zhi ; 101(11): 776-781, 2021 Mar 23.
Article in Chinese | MEDLINE | ID: mdl-33765717

ABSTRACT

Objective: To investigate the effect of remote ischemic preconditioning (RIPC) on contrast-induced acute kidney injury (CI-AKI) in patients with chronic total occlusion (CTO) after percutaneous coronary intervention (PCI). Methods: A total of 282 patients undergoing PCI at Zhongda Hospital Affiliated to Southeast University between June 2017 and January 2019 were prospectively enrolled. The patients were randomly divided into RIPC group (n=142) and control group (n=140). CI-AKI was defined as an increase in level of cystatin C (CysC)≥10% above baseline at 24 h after contrast administration. Baseline characteristics and the incidence of CI-AKI were compared between the two groups. The multivariate logistic regression analysis was further used to analyze the independent risk factors of CI-AKI. Results: There were no significant differences in age, gender, smoking, hypertension, diabetes, stroke and old myocardial infarction, coronary artery bypass graft surgery, previous PCI history and laboratory test indicators, target vessel and pathological characteristics of CTO lesions, contrast agent dosage, J-CTO (Multicenter CTO Registry in Japan) score, SYNTAX (Synergy between Percutaneous Coronary Intervention with Taxus and Cardiac Surgery) score, PCI success rate and stent number between the two groups (P>0.05). The incidence of CI-AKI was significantly lower (18.3% vs 29.3%, P=0.036) in RIPC group than that of control group. Multivariate logistic analysis found that creatinine [odds ratio (OR)=1.018,95%CI: 1.006-1.030, P=0.003], CysC (OR=5.200, 95%CI:2.714-9.963, P<0.001),contrast agent dosage (OR=1.013,95%CI: 1.007-1.019, P<0.001) and J-CTO score (OR=1.834, 95%CI: 1.145-2.939, P=0.012) were independent risk factors of CI-AKI. However, RIPC was an independent protective factor of CI-AKI (OR=0.391, 95%CI: 0.199-0.765, P=0.006). Conclusion: RIPC before contrast agent administration prevents CI-AKI in CTO patients undergoing PCI.


Subject(s)
Acute Kidney Injury , Ischemic Preconditioning , Percutaneous Coronary Intervention , Acute Kidney Injury/chemically induced , Acute Kidney Injury/prevention & control , Contrast Media/adverse effects , Humans , Japan , Risk Factors
5.
Eur Rev Med Pharmacol Sci ; 24(18): 9581-9590, 2020 09.
Article in English | MEDLINE | ID: mdl-33015801

ABSTRACT

OBJECTIVE: Long non-coding RNAs (lncRNAs) participate in multiple processes of malignant tumors, including glioma. In this study, we aimed to explore the effect of LINC00346 on glioma and its underlying mechanism. MATERIALS AND METHODS: The Cancer Genome Atlas (TCGA) and the Chinese Glioma Genome Atlas (CGGA) databases were used to analyze the expression patterns and survival risk of LINC00346, miR-128-3p and SUZ RNA binding domain containing 1 (SZRD1) in glioma tissues. The binding sites were predicted by bioinformatic databases, and then, validated by Dual-Luciferase assay and RNA immunoprecipitation (RIP). qRT-PCR and Western blot were performed to evaluate the gene expression levels. CellTiter-Glo® and colony formation assays were used to detect the proliferation of glioma cells. Flow cytometric analysis was used to evaluate the apoptosis of glioma cells. The xenograft models were established to investigate the impact of LINC00346 on tumor growth in vivo. RESULTS: We found that both LINC00346 and SZRD1 expression were negatively related to the poor overall survival rate in glioma patients. However, miR-128-3p showed the opposite effect of survival outcomes. LINC00346 knockdown remarkably restrained cell proliferation both in vitro and in vivo, as well as inducing apoptosis by acting as a molecular sponge of miR-128-3p. Moreover, miR-128-3p bound to SZRD1 3'-UTR in a sequence-specific manner. In addition, LINC00346 knockdown significantly inhibited the expression of SZRD1 and the inhibition could be reversed by miR-128-3p mimics. Furthermore, cell proliferation and apoptosis affected by LINC00346 were partially rescued by modulating miR-128-3p or SZRD1 expression. CONCLUSIONS: LINC00346/miR-128-3p/SZRD1 axis played a crucial role in modulating the malignant progression of glioma, which may serve as a prognostic indicator and a probable therapeutic target for glioma.


Subject(s)
Apoptosis , Brain Neoplasms/metabolism , Glioma/metabolism , MicroRNAs/metabolism , RNA, Long Noncoding/metabolism , Animals , Brain Neoplasms/pathology , Cell Proliferation , Cells, Cultured , Glioma/pathology , Humans , Mice , Mice, Inbred BALB C , Mice, Nude , MicroRNAs/genetics , Neoplasms, Experimental/metabolism , Neoplasms, Experimental/pathology , RNA, Long Noncoding/genetics
6.
Clin Radiol ; 72(11): 936-943, 2017 Nov.
Article in English | MEDLINE | ID: mdl-28673449

ABSTRACT

AIM: To evaluate prospectively the performance of combining morphological and arterial spin labelling (ASL) magnetic resonance imaging (MRI) for detecting pseudocapsule defects in renal cell carcinoma (RCC), and to predict renal capsule invasion confirmed histopathologically. MATERIALS AND METHODS: Twenty consecutive patients with suspicious renal tumours underwent MRI. Renal ASL imaging was performed and renal blood flow was measured quantitatively. The diagnostic performance of T2-weighted images alone, and a combination of T2-weighted and ASL images for predicting renal capsule invasion were assessed. RESULTS: Twenty renal lesions were evaluated in 20 patients. All lesions were clear cell RCCs (ccRCCs) confirmed at post-surgical histopathology. Fifteen ccRCCs showed pseudocapsule defects on T2-weighted images, of which 12 cases showed existing blood flow in defect areas on perfusion images. To predict renal capsule invasion, the sensitivity, specificity, positive predictive value, and negative predictive value were 100%, 71.4%, 86.7%, 100%, respectively, for T2-weighted images alone, and 92.3%, 100%, 100%, 87.5%, respectively, for the combination of T2-weighted and ASL images. CONCLUSION: ASL images can reflect the perfusion of pseudocapsule defects and as such, the combination of T2-weighted and ASL images produces promising diagnostic accuracy for predicting renal capsule invasion.


Subject(s)
Carcinoma, Renal Cell/diagnostic imaging , Carcinoma, Renal Cell/pathology , Kidney Neoplasms/diagnostic imaging , Kidney Neoplasms/pathology , Magnetic Resonance Imaging/methods , Adolescent , Adult , Aged , Female , Humans , Kidney/diagnostic imaging , Kidney/pathology , Male , Middle Aged , Prospective Studies , Reproducibility of Results , Sensitivity and Specificity , Spin Labels , Young Adult
7.
CPT Pharmacometrics Syst Pharmacol ; 5(8): 418-26, 2016 08.
Article in English | MEDLINE | ID: mdl-27537780

ABSTRACT

A systems model was developed to describe the metabolism and disposition of ursodeoxycholic acid (UDCA) and its conjugates in healthy subjects based on pharmacokinetic (PK) data from published studies in order to study the distribution of oral UDCA and potential interactions influencing therapeutic effects upon interruption of its enterohepatic recirculation. The base model was empirically adapted to patients with primary biliary cirrhosis (PBC) based on current understanding of disease pathophysiology and clinical measurements. Simulations were performed for patients with PBC under two competing hypotheses: one for inhibition of ileal absorption of both UDCA and conjugates and the other only of conjugates. The simulations predicted distinctly different bile acid distribution patterns in plasma and bile. The UDCA model adapted to patients with PBC provides a platform to investigate a complex therapeutic drug interaction among UDCA, UDCA conjugates, and inhibition of ileal bile acid transport in this rare disease population.


Subject(s)
Cholagogues and Choleretics/metabolism , Liver Cirrhosis, Biliary/metabolism , Systems Analysis , Ursodeoxycholic Acid/metabolism , Administration, Oral , Bile Acids and Salts/metabolism , Cholagogues and Choleretics/administration & dosage , Databases, Factual/statistics & numerical data , Humans , Ileum/drug effects , Ileum/metabolism , Liver Cirrhosis, Biliary/drug therapy , Random Allocation , Ursodeoxycholic Acid/administration & dosage
8.
Beijing Da Xue Xue Bao Yi Xue Ban ; 48(2): 287-91, 2016 Apr 18.
Article in Chinese | MEDLINE | ID: mdl-27080283

ABSTRACT

OBJECTIVE: To investigate the feasibility of dynamic contrast-enhanced magnetic resonance imaging (DCE-MRI) parameters in differentiating musculoskeletal tumors with different behaviours of pathological findings before therapy. METHODS: A total of 34 subjects of musculoskeletal tumors were involved in this retrospective analysis. DCE-MRI was performed using a fat-saturated 3D VIBE (volumetric interpolated breath-hold exam) imaging sequence with following parameters: FA, 10 degree; TR/TE, 5.6/2.4 ms; slice thickness, 4.0 mm with no intersection gap; field of view, 310 mm×213 mm; matrix, 256×178; voxel size, 1.2 mm×1.2 mm×4.0 mm; parallel imaging acceleration factor. The actuation time for the DCE-MRI sequence was 255 s with a temporal resolution of 5 s and 40 image volumes. Using pathological results as a gold standard, tumors were divided into benign, borderline and malignant tumors. Toft's model was used for calculation of K(trans) (volume transfer constant), Ve (extravascular extracellular space distribute volume per unit tissue volume) and Kep (microvascular permeability reflux constant). Those parameters were compared between the lesions and the control tissues using paired t tests. The one-way analysis of variance was used to assess the difference among benign, borderline and malignant tumors. P values <0.05 difference was statistically significant. RESULTS: Based on the WHO Classification of Tumours of Soft Tissue and Bone(2012) criteria, 34 patients were divided into three groups: 11 for benign tumors, 12 for borderline tumors, and 11 for malignancies. Compared with control tissues, K(trans) and Kep showed no difference, but Ve was increased in benign tumors, Kep showed no difference, but K(trans) and Ve were increased in borderline tumors,K(trans), Kep and Ve were increased in malignant tumors. K(trans) (P<0.001) and Kep (P<0.01) were significantly higher in malignant tumors than in benign and borderline tumors, but did not show any difference between benign tumors and borderline tumors. Ve was significantly higher in malignant tumors than in benign (P<0.05), but did not show any difference between malignant and borderline tumors, benign tumors and borderline tumors (P>0.05). CONCLUSION: DCE-MRI technique is useful to evaluate the pathological behaviour of musculoskeletal tumors. The quantitative analysis of DCE parameters in conjunction with conventional MR images can improve the accuracy of musculoskeletal tumor qualitative analysis.


Subject(s)
Magnetic Resonance Imaging , Musculoskeletal Diseases/diagnostic imaging , Neoplasms/diagnostic imaging , Contrast Media , Feasibility Studies , Humans , Neoplasms/classification , Retrospective Studies
9.
Diabetes Obes Metab ; 18(7): 654-62, 2016 07.
Article in English | MEDLINE | ID: mdl-26939572

ABSTRACT

AIMS: To investigate the pharmacodynamics, pharmacokinetics and safety/tolerability of blocking reuptake of bile acids using the inhibitor GSK2330672 (GSK672) in patients with type 2 diabetes (T2D). METHODS: Subjects with T2D taking metformin were enrolled in two studies in which they took metformin 850 mg twice daily for 2 weeks prior to and during the randomized treatment periods. In the first crossover study (n = 15), subjects received GSK672 45 mg, escalating to 90 mg, twice daily, or placebo for 7 days. The second parallel-group study (n = 75) investigated GSK672 10-90 mg twice daily, placebo or sitagliptin for 14 days. RESULTS: In both studies, GSK672 reduced circulating bile acids and increased serum 7-α-hydroxy-4-cholesten-3-one (C4), an intermediate in the hepatic synthesis of bile acids. Compared with placebo, in the parallel-group study 90 mg GSK672 twice daily reduced fasting plasma glucose [FPG; -1.21 mmol/l; 95% confidence interval (CI) -2.14, -0.28] and weighted-mean glucose area under the curve (AUC)0-24 h (-1.33 mmol/l; 95% CI -2.30, -0.36), as well as fasting and weighted-mean insulin AUC0 -24 h . GSK672 also reduced cholesterol (LDL, non-HDL and total cholesterol) and apolipoprotein B concentrations; the maximum LDL cholesterol reduction was ∼40%. There was no change in HDL cholesterol but there was a trend towards increased fasting triglyceride levels in the GSK672 groups compared with placebo. In both studies, the most common adverse events associated with GSK672 were gastrointestinal, mostly diarrhoea (22-100%), which appeared to be independent of dose. CONCLUSIONS: In subjects with T2D on metformin, GSK672 improved glucose and lipids, but there was a high incidence of gastrointestinal adverse events.


Subject(s)
Diabetes Mellitus, Type 2/drug therapy , Hypoglycemic Agents/administration & dosage , Metformin/administration & dosage , Methylamines/administration & dosage , Thiazepines/administration & dosage , Adult , Apolipoproteins B/metabolism , Area Under Curve , Bile Acids and Salts/metabolism , Blood Glucose/metabolism , Cholesterol, LDL , Cross-Over Studies , Diarrhea/chemically induced , Double-Blind Method , Drug Administration Schedule , Fasting/metabolism , Female , Gastrointestinal Diseases/chemically induced , Humans , Hypoglycemic Agents/adverse effects , Hypoglycemic Agents/pharmacology , Insulin/metabolism , Lipid Metabolism/drug effects , Male , Metformin/adverse effects , Metformin/pharmacology , Methylamines/adverse effects , Methylamines/pharmacology , Middle Aged , Organic Anion Transporters, Sodium-Dependent/antagonists & inhibitors , Symporters/antagonists & inhibitors , Thiazepines/adverse effects , Thiazepines/pharmacology , Treatment Outcome
10.
Nutr Metab Cardiovasc Dis ; 25(6): 582-7, 2015 Jun.
Article in English | MEDLINE | ID: mdl-25921842

ABSTRACT

BACKGROUND AND AIMS: Dyslipidemia contributes to the development and progression of renal disease. The objective of this study was to investigate whether an elevated non-HDL-cholesterol to HDL-cholesterol ratio (NonHDLc/HDLc) predicts new-onset chronic kidney disease (CKD). METHODS AND RESULTS: We followed 1891 Chinese adults with normal or near-normal kidney function at baseline who participated in an annual health checkup program for the occurrence of new-onset CKD [defined as an estimated glomerular filtration rate (eGFR) of <60 mL/min/1.73 m(2) (low eGFR) and/or proteinuria (defined as urinary protein ≥1 + on dipstick testing)] or low eGFR. Cox proportional hazards models were used to examine the independent relationship between the plasma NonHDLc/HDLc ratio and new-onset CKD. During a median follow-up period of 2.8 years, 3% (n = 57) of participants developed new-onset CKD. Compared with patients in the lowest tertile, patients with NonHDLc/HDLc ratios in the highest tertile had a 1.45-fold higher risk of new-onset CKD (hazard ratio [HR], 2.45; 95% confidence interval [95% CI], 1.07 to 5.61; P = 0.035) after adjustment for potential confounders. There was a marginally significant association with low eGFR (tertile 3 versus tertile 1: HR, 2.94; 95% CI, 0.98 to 8.82; P = 0.054). CONCLUSIONS: NonHDLc/HDLc ratio is an independent risk factor for the development of CKD. Assessment of NonHDLc/HDLc ratio may help identify high risk groups with chronic kidney disease.


Subject(s)
Cholesterol, HDL/blood , Cholesterol/blood , Dyslipidemias/complications , Renal Insufficiency, Chronic/etiology , Adult , Biomarkers/blood , Chi-Square Distribution , China , Dyslipidemias/blood , Dyslipidemias/diagnosis , Female , Glomerular Filtration Rate , Humans , Kidney/physiopathology , Longitudinal Studies , Male , Middle Aged , Predictive Value of Tests , Prognosis , Proportional Hazards Models , Proteinuria/etiology , Renal Insufficiency, Chronic/diagnosis , Renal Insufficiency, Chronic/physiopathology , Risk Assessment , Risk Factors , Time Factors
11.
J Mol Neurosci ; 53(3): 487-92, 2014 Jul.
Article in English | MEDLINE | ID: mdl-24385195

ABSTRACT

The genetic manipulation of the laboratory mouse has been well developed and generated more and more mouse lines for biomedical research. To advance our science exploration, it is necessary to share genetically modified mouse lines with collaborators between institutions, even in different countries. The transfer process is complicated. Significant paperwork and coordination are required, concerning animal welfare, intellectual property rights, colony health status, and biohazard. Here, we provide a practical example of importing a transgenic mice line, Dynamin 1 knockout mice, from Yale University in the USA to Perking University in China for studying cell secretion. This example including the length of time that required for paper work, mice quarantine at the receiving institution, and expansion of the mouse line for experiments. The procedure described in this paper for delivery live transgenic mice from USA to China may serve a simple reference for transferring mouse lines between other countries too.


Subject(s)
Breeding/methods , Genotyping Techniques/methods , Mice, Knockout/genetics , Animal Care Committees , Animals , China , Dynamin I/genetics , Laboratory Animal Science/methods , Laboratory Animal Science/standards , Mice , Mice, Knockout/physiology , Universities
12.
Neoplasma ; 61(2): 153-60, 2014.
Article in English | MEDLINE | ID: mdl-24299311

ABSTRACT

Lung cancer remains a major cause of cancer-related lethality because of high incidence and recurrence in spite of significant advances in staging and therapy. In present study, we identified a subpopulation of cells isolated from the A549 cell line with marker CD133. In vivo results showed that A549 CD133+ cells displayed high liver metastatic potential. Severe liver cell damage with tumor cell invasion revealed by pathological examination and these changes were consistent with the results of serological tests where the plasma GPT and GOT level are significantly higher than that of the control group. Compared with A549 cells, A549 CD133+ cells expressed high levels of VEGF and exhibited high migration and invasion capability. In conclusion, we first reported that A549 CD133+ cells exhibited characteristic of high liver metastatic potential which makes it be a suitable model for further study of liver metastasis of lung adenocarcinoma and provide a potential platform for anti-metastatic drug discovery or evaluation.


Subject(s)
Adenocarcinoma/metabolism , Antigens, CD/genetics , Glycoproteins/genetics , Liver Neoplasms/genetics , Lung Neoplasms/metabolism , Neoplasm Metastasis/pathology , Peptides/genetics , AC133 Antigen , Adenocarcinoma/pathology , Adenocarcinoma of Lung , Antigens, CD/immunology , Antigens, CD/metabolism , Cell Line, Tumor , Cell Movement/genetics , Cell Movement/immunology , Cell Proliferation , Cell Survival/genetics , Cell Survival/immunology , Glycoproteins/immunology , Glycoproteins/metabolism , Humans , Liver Neoplasms/immunology , Liver Neoplasms/pathology , Liver Neoplasms/secondary , Lung Neoplasms/pathology , Neoplasm Metastasis/genetics , Neoplasm Recurrence, Local/genetics , Neoplasm Recurrence, Local/pathology , Peptides/immunology , Peptides/metabolism
13.
Antimicrob Agents Chemother ; 57(7): 3194-201, 2013 Jul.
Article in English | MEDLINE | ID: mdl-23629714

ABSTRACT

Azithromycin (AZI), a broad-spectrum antibiotic, accumulates in polymorphonuclear cells and peripheral blood mononuclear cells. The distribution of AZI in proinflammatory cells may be important to the anti-inflammatory properties. Previous studies have described plasma AZI pharmacokinetics. The objective of this study was to describe the pharmacokinetics of AZI in whole blood (concentration in whole blood [Cb]) and plasma (concentration in plasma [Cp]) of healthy subjects. In this study, 12 subjects received AZI (500 mg once a day for 3 days). AZI Cb and Cp were quantified in serial samples collected up to 3 weeks after the last dose and analyzed using noncompartmental and compartmental methods. After the last dose, Cb was greater than Cp. Importantly, Cb, but not Cp, was quantifiable in all but one subject at 3 weeks. The blood area under the curve during a 24-h dosing interval (AUC24) was ∼2-fold greater than the plasma AUC24, but simulations suggested that Cb was not at steady state by day 3. Upon exploration of numerous models, an empirical 3-compartment model adequately described Cp and Cb, but Cp was somewhat underestimated. Intercompartmental clearance (CL; likely representing cells) was lower than apparent oral CL (18 versus 118 liters/h). Plasma, peripheral, and cell compartmental volumes were 439 liters, 2,980 liters, and 3,084 liters, respectively. Interindividual variability in CL was low (26.2%), while the volume of distribution variability was high (107%). This is the first report to describe AZI Cb in healthy subjects, the distribution parameters between Cp and Cb, and AZI retention in blood for up to 3 weeks following 3 daily doses. The model can be used to predict Cb from Cp for AZI under various dosing regimens. (This study has been registered at ClinicalTrials.gov under registration no. NCT01026064.).


Subject(s)
Anti-Bacterial Agents/blood , Azithromycin/blood , Administration, Oral , Adult , Half-Life , Humans , Leukocytes, Mononuclear/drug effects , Male , Middle Aged , Neutrophils/drug effects , Plasma , Young Adult
14.
J Clin Endocrinol Metab ; 96(6): 1763-70, 2011 Jun.
Article in English | MEDLINE | ID: mdl-21411546

ABSTRACT

OBJECTIVE: Our objective was to examine the mechanisms via which exenatide attenuates postprandial hyperglycemia in type 2 diabetes mellitus (T2DM). STUDY DESIGN: Seventeen T2DM patients (44 yr; seven females, 10 males; body mass index = 33.6 kg/m(2); glycosylated hemoglobin = 7.9%) received a mixed meal followed for 6 h with double-tracer technique ([1-(14)C]glucose orally; [3-(3)H]glucose i.v.) before and after 2 wk of exenatide. In protocol II (n = 5), but not in protocol I (n = 12), exenatide was given in the morning of the repeat meal. Total and oral glucose appearance rates (RaT and RaO, respectively), endogenous glucose production (EGP), splanchnic glucose uptake (75 g - RaO), and hepatic insulin resistance (basal EGP × fasting plasma insulin) were determined. RESULTS: After 2 wk of exenatide (protocol I), fasting plasma glucose decreased (from 10.2 to 7.6 mm) and mean postmeal plasma glucose decreased (from 13.2 to 11.3 mm) (P < 0.05); fasting and meal-stimulated plasma insulin and glucagon did not change significantly. After exenatide, basal EGP decreased (from 13.9 to 10.8 µmol/kg · min, P < 0.05), and hepatic insulin resistance declined (both P < 0.05). RaO, gastric emptying (acetaminophen area under the curve), and splanchnic glucose uptake did not change. In protocol II (exenatide given before repeat meal), fasting plasma glucose decreased (from 11.1 to 8.9 mm) and mean postmeal plasma glucose decreased (from 14.2 to 10.1 mm) (P < 0.05); fasting and meal-stimulated plasma insulin and glucagon did not change significantly. After exenatide, basal EGP decreased (from 13.4 to 10.7 µmol/kg · min, P = 0.05). RaT and RaO decreased markedly from 0-180 min after meal ingestion, consistent with exenatide's action to delay gastric emptying. CONCLUSIONS: Exenatide improves 1) fasting hyperglycemia by reducing basal EGP and 2) postmeal hyperglycemia by reducing the appearance of oral glucose in the systemic circulation.


Subject(s)
Blood Glucose/drug effects , Diabetes Mellitus, Type 2/metabolism , Hypoglycemic Agents/pharmacology , Peptides/pharmacology , Postprandial Period/drug effects , Venoms/pharmacology , Adult , Area Under Curve , Blood Glucose/metabolism , Exenatide , Female , Glucagon/blood , Glycated Hemoglobin/metabolism , Humans , Insulin/blood , Male , Middle Aged , Postprandial Period/physiology
15.
Curr Alzheimer Res ; 8(4): 410-20, 2011 Jun.
Article in English | MEDLINE | ID: mdl-21244354

ABSTRACT

It has been demonstrated that the onset and progression of Alzheimer's disease (AD) are associated with inflammatory disorders in the brain. Although the interactions of inflammatory cytokines with neurotrophins have been reported in vitro, the balance change between inflammatory cytokines and neurotrophic factors (NTFs), such as nerve growth factor (NGF), brain derived neurotrophic factor (BDNF), and glial cell line-derived neurotrophic factor (GDNF), due to amyloid ß (Aß) chronic administration in vivo is still unclear. The hypothesis of the present study was that the accumulation of Aß activated glial cells to produce inflammatory mediators and NTFs to maintain the neurons survival, however the failure of crosstalk between NTFs and inflammatory cytokines might occur in the brain and the NTFs expressions would decrease after Aß chronic treatment, which, therefore, would contribute to the neuronal death and memory impairments. Thus, the present study measured the learning and memory behavior, glial cells activities, cytokines (IL-1α, IL-1ß and TNF-α) concentrations and NTFs (NGF, BDNF and GDNF) gene and protein levels in rats after i.c.v injection of Aß(25-35) for 14 days. The results showed that Aß (25-35)-treated animals exhibited failure of balance between inflammatory cytokines and NTFs system (increased cytokines levels, decreased NGF protein expression and reduced NTFs gene transcriptions), which might contribute to the cognitive impairments. The findings from this study provide valuable evidence that correct regulation of the crosstalk between inflammatory cytokines and NTFs could be a direction for AD therapy in the future.


Subject(s)
Amyloid beta-Peptides/toxicity , Cytokines/metabolism , Hippocampus/drug effects , Memory Disorders , Nerve Growth Factors/metabolism , Peptide Fragments/toxicity , Animals , Disease Models, Animal , Enzyme-Linked Immunosorbent Assay/methods , Glial Fibrillary Acidic Protein/metabolism , Hippocampus/metabolism , Injections, Intraventricular/methods , Male , Maze Learning/drug effects , Memory Disorders/chemically induced , Memory Disorders/metabolism , Memory Disorders/pathology , Rats , Rats, Long-Evans
16.
Opt Express ; 18(15): 16183-92, 2010 Jul 19.
Article in English | MEDLINE | ID: mdl-20721004

ABSTRACT

Transfer of spectral phase from near infrared ultrashort pulses to deep ultraviolet (UV) sub-30-fs pulses through four-wave mixing process is demonstrated. Micro joule UV pulses at 237 nm were generated by nonlinear mixing of second harmonic pulses of Ti:sapphire laser output and near infrared pulses from a noncollinear optical parametric amplifier. Chirp of the near infrared pulse was transferred to the UV pulse with the opposite sign. A positively chirped near infrared pulse was used for generating a negatively chirped UV pulse, which was compressed down to 25 fs by a magnesium fluoride window.

17.
J Appl Microbiol ; 109(4): 1311-8, 2010 Oct.
Article in English | MEDLINE | ID: mdl-20477900

ABSTRACT

AIMS: To investigate the bactericidal activity of lactoferrin-derived peptides and a new LF-derived peptides chimera (LFchimera) against P. aeruginosa and the influence on virulence factors of P. aeruginosa. METHODS AND RESULTS: Lactoferricin (LFcin) and lactoferrampin (LFampin) are highly bioactive peptides isolated from the N-terminal region of lactoferrin (LF) by pepsin digestion. In this study, we designed LFchimera containing LFcin amino acids 17-30 and LFampin amino acids 268-284. Pseudomonas aeruginosa cells were incubated in medium with peptides at different concentrations, and then the assays of viability, pyocyanin, elastase activity and biofilm formation of P. aeruginosa were performed. We found that the concentration-dependent antibactericidal activity and down-regulating pyocyanin, elastase and biofilm formation of LFchimera were significantly stronger than those of LF, LFcin, LFampin or LFcin plus LFampin. CONCLUSIONS: Our results indicated that LF, LFcin, LFampin and LFchimera were potential candidates to combat P. aeruginosa, and LFchimera was the most effective in them. SIGNIFICANCE AND IMPACT OF THE STUDY: The new LFchimera has better activity against P. aeruginosa than LF, LFcin and LFampin and may be a promising new compound for treatment of P. aeruginosa infection.


Subject(s)
Anti-Bacterial Agents/pharmacology , Antimicrobial Cationic Peptides/pharmacology , Biofilms/drug effects , Peptides/pharmacology , Pseudomonas aeruginosa/drug effects , Virulence Factors/biosynthesis , Animals , Anti-Bacterial Agents/chemistry , Antimicrobial Cationic Peptides/chemistry , Lactoferrin/chemistry , Lactoferrin/pharmacology , Peptide Fragments/chemistry , Peptide Fragments/pharmacology , Peptides/chemistry , Pseudomonas aeruginosa/pathogenicity , Pseudomonas aeruginosa/physiology , Pyocyanine/biosynthesis
18.
Phys Rev Lett ; 105(19): 195007, 2010 Nov 05.
Article in English | MEDLINE | ID: mdl-21231178

ABSTRACT

Here is reported in situ observation of energetic electrons (∼100-500 keV) associated with magnetic reconnection in the solar wind by the ACE and Wind spacecraft. The properties of this magnetic cloud driving reconnection and the associated energetic electron acceleration problem are discussed. Further analyses indicate that the electric field acceleration and Fermi-type mechanism are two fundamental elements in the electron acceleration processes and the trapping effect of the specific magnetic field configuration maintains the acceleration status that increases the totally gained energy.

19.
Phys Chem Chem Phys ; 11(34): 7430-6, 2009 Sep 14.
Article in English | MEDLINE | ID: mdl-19690715

ABSTRACT

The anionic soluble heme protein cytochrome b(562) was electrostatically immobilised on Ag electrodes coated with positively charged self-assembled monolayers of amino-terminated alkanethiols. The structure of the heme pocket, the redox equilibria, and the electron transfer dynamics were studied by stationary and time-resolved surface enhanced resonance Raman spectroscopy, complemented by cyclic voltammetry measurements of the interfacial redox process. The conformational and redox equilibria of the immobilised protein are compared to those of the cationic heme protein cytochrome c immobilised on negatively charged electrode coatings. Similarities and differences can be rationalised in terms of the respective electric fields at the interfaces of amino- and carboxyl-terminated electrode coatings. The heterogeneous electron transfer rate of cytochrome b(562) only slightly increases with decreasing thickness from ca. 20 to 11 A, implying that the electron tunneling is not the rate-limiting step. In contrast to cytochrome c on carboxyl-terminated monolayers, this behaviour cannot be attributed to protein re-orientation gating the heterogeneous electron transfer. Instead, it may reflect the interplay between interprotein electron transfer and heterogeneous electron transfer via protein orientations exhibiting particularly high tunneling probabilities for the electron exchange with the electrode.


Subject(s)
Cytochrome b Group/chemistry , Escherichia coli Proteins/chemistry , Electrodes , Enzymes, Immobilized/chemistry , Oxidation-Reduction , Silver/chemistry , Static Electricity , Thermodynamics
20.
Neuroscience ; 155(1): 234-40, 2008 Jul 31.
Article in English | MEDLINE | ID: mdl-18585441

ABSTRACT

Nerve growth factor (NGF) is a potential drug for Alzheimer's disease treatment, but delivering NGF to the brain is difficult. To increase the content of NGF in brain, we prepared cholera toxin B subunit (CB) -NGF by the improved sodium metaperiodate method and compared its pharmacodynamics with NGF. In vitro, CB-NGF, as well as NGF, could promote neurite outgrowth and increase choline acetyltransferase activities. But the time window of TrkA phosphorylation induced by CB-NGF and NGF was different. In vivo, nasal administration of CB-NGF could increase the stay time and partially improve abilities of space learning and memory in amnesic mice, and protected the cholinergic neurons in basal forebrain against Abeta(25-35). CB-NGF treatment has better curative effects than NGF in Alzheimer's disease model mice.


Subject(s)
Adjuvants, Immunologic/administration & dosage , Amnesia/drug therapy , Cholera Toxin/administration & dosage , Learning/drug effects , Nerve Growth Factor/administration & dosage , Space Perception/drug effects , Administration, Intranasal , Amnesia/chemically induced , Amyloid beta-Peptides/chemistry , Amyloid beta-Peptides/toxicity , Animals , Behavior, Animal/drug effects , Choline O-Acetyltransferase/metabolism , Disease Models, Animal , Dose-Response Relationship, Drug , Gene Expression Regulation/drug effects , Male , Maze Learning/drug effects , Mice , Mice, Inbred BALB C , Neurites/drug effects , Neurites/physiology , PC12 Cells/cytology , PC12 Cells/drug effects , Peptide Fragments , Rats , Time Factors
SELECTION OF CITATIONS
SEARCH DETAIL
...